129 related articles for article (PubMed ID: 406999)
21. [Differences in autonomy of the growth hormone secretion in patients with acromegaly (author's transl)].
Hanew K
Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):25-37. PubMed ID: 105940
[No Abstract] [Full Text] [Related]
22. The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.
Lamberts SW; Klijn JG; Kwa GH; Birkenhäger JC
Acta Endocrinol (Copenh); 1979 Feb; 90(2):198-210. PubMed ID: 105530
[No Abstract] [Full Text] [Related]
23. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
Felt V; Nedvídková J
Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
[No Abstract] [Full Text] [Related]
24. Regulation of growth hormone and prolactin secretion in patients with acromegaly and-or excessive prolactin secretion.
Cryer PE; Jacobs LS; Daughaday WH
Mt Sinai J Med; 1973; 40(3):402-13. PubMed ID: 4197309
[No Abstract] [Full Text] [Related]
25. [Dynamic evaluation of GH secretion in acromegaly as a criterion for the choice of treatment].
Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
Clin Ter; 1977 Aug; 82(3):203-12. PubMed ID: 410583
[No Abstract] [Full Text] [Related]
26. [Dopamine and pituitary hormones. Physiology and pathology (author's transl)].
Saltiel H; Thomopoulos P
Ann Endocrinol (Paris); 1981 Dec; 42(6):497-516. PubMed ID: 6285797
[TBL] [Abstract][Full Text] [Related]
27. [Effect of thyroliberin on prolactin and thyrotropin secretion in patients with primary hypothyroidism].
Dorobek W; Drac-Kaniewska J; Jeske W
Pol Tyg Lek; 1985 Jul; 40(27):756-8. PubMed ID: 3931065
[No Abstract] [Full Text] [Related]
28. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly.
Maeda K
Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578
[No Abstract] [Full Text] [Related]
29. Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.
Ishibashi M; Yamaji T; Kosaka K
J Clin Endocrinol Metab; 1978 Aug; 47(2):418-21. PubMed ID: 400720
[TBL] [Abstract][Full Text] [Related]
30. Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
Tallo D; Malarkey WB
J Clin Endocrinol Metab; 1981 Dec; 53(6):1278-84. PubMed ID: 7298804
[No Abstract] [Full Text] [Related]
31. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
Ishibashi M; Yamaji T; Kosaka K
J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240
[TBL] [Abstract][Full Text] [Related]
32. [Response of growth hormone to sandostatin and bromocriptine and prognostic value of prolactin levels in serum and thyroliberin test in patients with active acromegaly].
Gasińska T; Nowak S
Endokrynol Pol; 1993; 44(4):455-65. PubMed ID: 8055814
[TBL] [Abstract][Full Text] [Related]
33. Pituitary vasoactive intestinal peptide regulates prolactin secretion in the hypothyroid rat.
Lam KS; Reichlin S
Neuroendocrinology; 1989 Nov; 50(5):524-8. PubMed ID: 2514393
[TBL] [Abstract][Full Text] [Related]
34. [Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism].
Campino C; Pumarino H; Michelsen H; Piraino P; Generini G; Bruggendieck B
Rev Med Chil; 1985 Apr; 113(4):296-300. PubMed ID: 3915142
[No Abstract] [Full Text] [Related]
35. [Recent advances in hormonal detection of pituitary somatotropic adenomas (author's transl)].
Turpin G; Heshmati HM; De Gennes JL
Ann Med Interne (Paris); 1982; 133(1):17-22. PubMed ID: 6802054
[TBL] [Abstract][Full Text] [Related]
36. [Nycterohemeral variations of growth hormone and prolactin in 6 Parkinson's sufferers treated with bromocriptine (author's transl)].
Passouant P; Besset A; Descomps B; Bonardet A; Billiard M; Nègre C
Nouv Presse Med; 1979 Oct; 8(40):3237-42. PubMed ID: 534183
[TBL] [Abstract][Full Text] [Related]
37. [Galactorrhea and prolactin secretion in acromegaly].
Bozadzhieva E; Savov G; Naĭdenov E; Ankov V; Kirilov G
Probl Endokrinol (Mosk); 1980; 26(2):20-5. PubMed ID: 6769107
[TBL] [Abstract][Full Text] [Related]
38. Bromocriptine and TRH-induced growth hormone release in anorexia nervosa.
Harrower AD; Yap PL; Nairn IM; Strong JA
Br Med J; 1977 Jul; 2(6081):264. PubMed ID: 406962
[No Abstract] [Full Text] [Related]
39. Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man.
Thorner MO; Ryan SM; Wass JA; Jones A; Bouloux P; Williams S; Besser GM
J Clin Endocrinol Metab; 1978 Aug; 47(2):372-8. PubMed ID: 45463
[TBL] [Abstract][Full Text] [Related]
40. [The use of thyreoliberin VUFB in the diagnosis of acromegaly (author's transl)].
Felt V; Nedvídková J; Shameti H; Kasafírek E
Cas Lek Cesk; 1979 Feb; 118(8):232-4. PubMed ID: 109212
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
